SBSylvain Bartolami

Sylvain Bartolami

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sylvain Bartolami has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Christian Chabbert

    Institut National de la Santé et de la Recherche Médicale U 1051, Institut des Neurosciences de Montpellier, Hôpital Saint Eloi, 34091 Montpellier cedex 5, France

    1 shared publication
  • Cécile Travo

    Institut National de la Santé et de la Recherche Médicale U 1051, Institut des Neurosciences de Montpellier, Hôpital Saint Eloi, 34091 Montpellier cedex 5, France

    1 shared publication
  • Jacques Barhanin

    Transport Ionique Aspects Normaux et Pathologiques, UMR CNRS 6097, Université de Nice–Sophia Antipolis, Faculté des Sciences ParcValrose, 06108 Nice cedex 2, France, and

    1 shared publication
  • Julie Quentin

    Institut National de la Santé et de la Recherche Médicale U 1051, Institut des Neurosciences de Montpellier, Hôpital Saint Eloi, 34091 Montpellier cedex 5, France

    1 shared publication
  • Mélanie Cavalier

    Institut National de la Santé et de la Recherche Médicale U 1051, Institut des Neurosciences de Montpellier, Hôpital Saint Eloi, 34091 Montpellier cedex 5, France

    1 shared publication
  • Nicolas Tricaud

    INSERM

    1 shared publication

Latest Publications

  • Open Access

    Quand trop de myélinisation détruit la myéline

    by Sylvain Bartolami, Nicolas Tricaud

  • Open Access

    Critical Roles of Transitional Cells and Na/K-ATPase in the Formation of Vestibular Endolymph

    by Sylvain Bartolami, Sophie Gaboyard, Julie Quentin, Cécile Travo, Mélanie Cavalier, Jacques Barhanin, Christian Chabbert

    The mechanotransduction of vestibular sensory cells depends on the high endolymphatic potassium concentration ([K+]) maintained by a fine balance between K+secretion and absorption by epithelial cells. Despite the crucial role of endolymph as an electrochemical motor for mechanotransduction, little is known about the processes that govern endolymph formation. To address these, we took advantage of an organotypic rodent model, which regenerates a genuine neonatal vestibular endolymphatic compartment, facilitating the determination of endolymphatic [K+] and transepithelial potential (Vt) during endolymph formation. While mature Vt levels are almost immediately achieved, K+accumulates to reach a steady [K+] by day 5 in culture. Inhibition of sensory cell K+efflux enhances [K+] regardless of the blocker used (FM1.43, amikacin, gentamicin, or gadolinium). Targeting K+secretion with bumetanide partially and transiently reduces [K+], while ouabain application andKcne1deletion almost abolishes it. Immunofluorescence studies demonstrate that dark cells do not express Na-K-2Cl cotransporter 1 (the target of bumetanide) in cultured and young mouse utricles, while Na/K-ATPase (the target of ouabain) is found in dark cells and transitional cells. This global analysis of the involvement of endolymphatic homeostasis actors in the immature organ (1) confirms that KCNE1 channels are necessary for K+secretion, (2) highlights Na/K-ATPase as the key endolymphatic K+provider and shows that Na-K-2Cl cotransporter 1 has a limited impact on K+influx, and (3) demonstrates that transitional cells are involved in K+secretion in the early endolymphatic compartment.